MICRO THERAPEUTICS, INC. DBA EV3

Manufacturer adverse-event records for MICRO THERAPEUTICS, INC. DBA EV3 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2011–2026 · mid-book · elevated Death-code · balanced

Death-code intensity

MICRO THERAPEUTICS, INC. DBA EV3 carries an elevated Death-code share

Death-coded event_type rows are 1,116 of 14,559 (7.67% · elevated tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for MICRO THERAPEUTICS, INC. DBA EV3

The standout signal for MICRO THERAPEUTICS, INC. DBA EV3 is Death-code intensity: 7.67% of 14,559 reports (elevated tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for MICRO THERAPEUTICS, INC. DBA EV3. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 9,400 (64.6% of event_type total). Peak single-year volume reaches 2,764 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

14,559
Total Reports
1,116
Event-type Death
4,043
Injury Reports
20
Device Types

Event Types

Malfunction 9,400 (64.6%)
Injury 4,043 (27.8%)
Death 1,116 (7.7%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

8,964 (57.7%)
Required Intervention 1,739 (11.2%)
Other 1,431 (9.2%)
Death 979 (6.3%)
Hospitalization 510 (3.3%)
R 481 (3.1%)
Life Threatening 306 (2.0%)
Disability 226 (1.5%)
H 224 (1.4%)
L 201 (1.3%)
S 172 (1.1%)
O 156 (1.0%)
D 150 (1.0%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

11
2011: 1
16
2016: 3
17
2017: 7
18
2018: 37
19
2019: 1,117
20
2020: 1,355
21
2021: 1,658
22
2022: 2,189
23
2023: 2,571
24
2024: 2,543
25
2025: 2,764
26
2026: 314